NIH-funded research R15 grant

Investigating how a specific gene affects cell division and cancer development

Official title: MTFR2 in the control of mitochondrial dynamics and mitotic spindle integrity

Funded at University of Toledo · NIH-10514925 · Data updated 2026-11-12

This study is looking at how a specific gene called MTFR2 affects the way cancer cells divide and how problems with cell energy can lead to mistakes in their genetic material, which could help us find new ways to treat cancer.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Toledo
NIH-funded
Lab location1 site (Toledo, United States)
Project startDecember 10, 2022
Project endNovember 30, 2025
Funding year2023
Award (this year)$451,500
NIH project number1R15GM147878-01
Project IDNIH-10514925 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with cancers that exhibit chromosomal instability.

Less likely to help

Patients with non-cancerous conditions or those whose cancers do not involve mitochondrial dysfunction may not benefit from this research.

What this research studies

This research focuses on understanding the role of the MTFR2 gene in regulating mitochondrial dynamics and its impact on cell division, particularly in cancer cells. The study aims to explore how defects in mitochondrial function can lead to errors in chromosome segregation during mitosis, which is crucial for maintaining genetic stability. By using advanced techniques like CRISPR to manipulate the MTFR2 gene, researchers will analyze its effects on cell behavior and cancer progression. Patients may benefit from insights gained about cancer cell behavior and potential new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating cancers by targeting the mechanisms of cell division.

How similar studies have gone: Previous research has shown that targeting mitochondrial dynamics can influence cancer cell behavior, suggesting a promising avenue for further exploration.

Where this research is happening

  • University of Toledo
    Toledo, United States
    Active

Researchers

  • Principal investigator: Liu, Song-Tao — University of Toledo
  • Study coordinator: Liu, Song-Tao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.